× Close

The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.

Items from 11 to 20 out of 144 results
customise view
items per page:
Previous Next

  • [11] M. Feldman and A.T. McMahan: “Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?”, Ann. Intern Med., Vol. 132(2), (2000), pp. 134–143.

  • [12] R.J. Flower: “Drugs which inhibit prostaglandin biosynthesis”, Pharmacol. Rev., Vol. 26(1), (1974), pp. 33–67.

  • RELATION NAME

  • RELATION NAME

  • RELATION NAME

  • [16] J.A. Oviedo and M. Wolfe: “Clinical potential of cyclooxygenase-2 inhibitors”, Bio Drugs, Vol. 15, (2001), pp. 563–572.

  • [17] V. Granados-Soto, R. Alonso-Lopez, R. Asomoza-Espinosa, M.O. Rufino, L.D. Gomes-Lopes and S.H. Ferrira: “Participation of COX, 1L-1β and TNFα in formalin-induced inflammatory pain”, Proceedings of the Western Pharmacology Society, Vol. 44, (2001), pp. 15–17.

  • RELATION NAME

  • [19] B. Nilsson, S. Friman and J. Svanvik: “Inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 regulates the microcirculation of the inflamed gall bladder”, Portland Press proceedings, Vol. 16, (2000), pp. 193; Chem. Abstr., Vol. 136, (2000), 277219z.

  • RELATION NAME

Previous Next